Related Experiment Video
Updated: May 22, 2026

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Characterization of lytic Pseudomonas aeruginosa bacteriophages via biological properties and genomic sequences
Natia Karumidze1, Julie A Thomas, Nino Kvatadze
1Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi, Georgia.
Abstract:
Pseudomonas aeruginosa is an important cause of infections, especially in patients with immunodeficiency or diabetes. Antibiotics are effective in preventing morbidity and mortality from Pseudomonas infection, but because of spreading multidrug-resistant bacterial strains, bacteriophages are being explored as an alternative therapy. Two newly purified broad host range Pseudomonas phages, named vB_Pae-Kakheti25 and vB_Pae-TbilisiM32, were characterized as candidates for use in phage therapy. Morphology, host range, growth properties, thermal stability, serology, genomic sequence, and virion composition are reported. When phages are used as bactericides, they are used in mixtures to overcome the development of resistance in the targeted bacterial population. These two phages are representative of diverse siphoviral and podoviral phage families, respectively, and hence have unrelated mechanisms of infection and no cross-antigenicity. Composing bactericidal phage mixtures with members of different phage families may decrease the incidence of developing resistance through a common mechanism.
Insights
Two new Pseudomonas phages, vB_Pae-Kakheti25 and vB_Pae-TbilisiM32, show promise for phage therapy against multidrug-resistant bacteria. Combining diverse phages may prevent bacterial resistance development.
Area of Science:
- Microbiology
- Virology
- Bacteriology
Background:
- Pseudomonas aeruginosa infections are a significant concern, particularly in immunocompromised individuals and those with diabetes.
- The rise of multidrug-resistant strains necessitates alternative therapeutic strategies beyond conventional antibiotics.
- Bacteriophages are emerging as a viable alternative for treating bacterial infections.
Purpose of the Study:
- To characterize two novel, broad-host-range Pseudomonas phages, vB_Pae-Kakheti25 and vB_Pae-TbilisiM32, as candidates for phage therapy.
- To evaluate their potential for use in combating multidrug-resistant Pseudomonas aeruginosa.
Main Methods:
- Purification and characterization of two Pseudomonas phages.
- Analysis of phage morphology, host range, growth properties, thermal stability, and serology.
- Genomic sequencing and virion composition analysis.
Main Results:
- vB_Pae-Kakheti25 (Siphoviridae) and vB_Pae-TbilisiM32 (Podoviridae) were successfully purified and characterized.
- The phages exhibit distinct infection mechanisms and lack cross-antigenicity, representing diverse phage families.
- Genomic and virion composition data were obtained for both phages.
Conclusions:
- These two phages are suitable candidates for phage therapy applications.
- Utilizing phage mixtures composed of members from different families, like these two, can reduce the incidence of bacterial resistance.
- Phage therapy offers a promising alternative to antibiotics for treating Pseudomonas aeruginosa infections.
Related Concept Videos
Lytic Cycle of Bacteriophages
DNA Bacteriophages
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle
Lysogenic Cycle of Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing

